VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,274,500 | +83.3% | 25,000 | +79.6% | 0.36% | +47.7% |
| Q2 2023 | $695,315 | -70.2% | 13,923 | -77.6% | 0.24% | -68.4% |
| Q1 2023 | $2,332,118 | -18.9% | 62,223 | +3.7% | 0.77% | -31.7% |
| Q4 2022 | $2,877,000 | +126.7% | 60,000 | +20.0% | 1.13% | +252.5% |
| Q3 2021 | $1,269,000 | +12.7% | 50,000 | 0.0% | 0.32% | -20.6% |
| Q2 2021 | $1,126,000 | +89.9% | 50,000 | +66.7% | 0.40% | +100.5% |
| Q1 2021 | $593,000 | -25.6% | 30,000 | 0.0% | 0.20% | -52.4% |
| Q4 2020 | $797,000 | – | 30,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |